Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Enoxaparin Generic Saga Continues: Momenta's Manufacturing Patent Invalid

Jul 23 2017

• By Brenda Sandburg

court house

Related Content

As Device Center Director Gets The Hook, Spotlight Turns To CDER's Woodcock

Aug 17 2009

Lovenox Generics: FDA’s Split Opinion On ANDA Approval Fully Supported By Court

Feb 07 2012

Manufacturing Patents In Peril After Court Extends Hatch-Waxman “Safe Harbor”

Aug 07 2012

Amphastar Seeks Court Order Requiring FDA To Approve Its Enoxaparin ANDA

Jan 03 2011

FDA Approves Momenta/Sandoz' Lovenox Generic Without Need For Clinical Studies

Jul 23 2010

Insider Trading By Ex-FDA Official Puts Spotlight On Agency Practices

Jun 27 2016

Related Companies

Momenta Pharmaceuticals, Inc.

Novartis AG

Sanofi

Amphastar Pharmaceuticals, Inc.

Novartis AG

Additional Topics

United States Generic Drugs Legal Issues Intellectual Property Policy BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window